9
34
Y. Qiong Ji et al. / Tetrahedron: Asymmetry 22 (2011) 929–935
(
90:10 n-hex: IPA, flow rate 0.8 ml/min, 215 nm); major enantio-
m), 5.44 (1H, m), 6.88–6.97 (3H, m), 7.28–7.57 (1H, m); 13C NMR
(CDCl , d ppm): 55.3, 70.9, 81.2, 111.50, 114.4, 118.1, 130.1,
1
mer t
1
= 15.37 min, minor enantiomer t
2
= 18.36 min; 87% ee;
H
3
NMR (CDCl
3
, d ppm): 2.89 (1H, s), 4.46–4.63 (2H, m), 5.47 (1H, d,
139.8 and 160.1.
13
J = 7.5 Hz), 7.07–7.13 (2H, m), 7.37–7.42 (2H, m); C NMR (CDCl
3
,
d ppm): 70.3, 81.2, 115.9, 116.1, 127.7 and 127.8.
4.2.13. (R)-1-(2-Methoxyphenyl)-2-nitroethanol (R)-3m
This compound was prepared according to the Section 4.2 and
purified by column chromatography (Hexane–EtOAc 9:1) to give
a yellow oil (79% yield); HPLC analysis: Chiralcel OD-H column
(90:10 n-hex: IPA, flow rate 1.0 ml/min, 215 nm); major enantio-
4
.2.7. (R)-1-(4-Methylphenyl)-2-nitroethanol (R)-3g
This compound was prepared according to the Section 4.2 and
purified by column chromatography (Hexane–EtOAc 8:1) to give
a colorless oil (65% yield); HPLC analysis: Chiralcel OD-H column
mer t
NMR (CDCl
1
= 11.14 min, minor enantiomer t
, d ppm): 3.24 (1H, d, J = 6 Hz), 3.90 (3H, s), 4.55–
= 12.91 min; 91% ee; 1
H
2
(
90:10 n-hex: IPA, flow rate 0.5 ml/min, 215 nm); major enantio-
3
1
mer t
NMR (CDCl
1
= 27.8 min, minor enantiomer t
2
= 35.6 min; 88% ee;
H
4.69 (2H, m), 5.62–5.68 (1H, m), 6.93 (1H, d, J = 8 Hz), 7.03 (1H, t,
3
, d ppm): 2.36 (3H, s), 2.48 (1H, s), 4.46–4.64 (2H,
J = 7.5 Hz), 7.35 (1H, t, J = 8 Hz), 7.46 (1H, d, J = 7.5 Hz); 13C NMR
13
m), 5.40–5.46 (1H, m), 7.26–7.30 (4H, m); C NMR (CDCl
ppm): 21.2, 70.9, 81.3, 125.9, 129.7, 135.2 and 139.0.
3
, d
3
(CDCl , d ppm): 55.4, 67.8, 79.9, 110.6, 121.2, 126.0, 127.2, 129.8
and 156.0.
4
.2.8. (R)-1-(3-Methylphenyl)-2-nitroethanol (R)-3h
This compound was prepared according to the Section 4.2 and
4.2.14. (R)-1-(2-Naphthyl)-2-nitroethanol (R)-3n
This compound was prepared according to the Section 4.2 and
purified by column chromatography (Hexane–EtOAc 4:1) to give
a yellow solid (85% yield); HPLC analysis: Chiralcel OD-H column
(85:15 n-hex: IPA, flow rate 0.8 ml/min, 215 nm); major enantio-
purified by column chromatography (Hexane–EtOAc 5:1) to give
a yellow oil (57% yield); HPLC analysis: Chiralcel OD-H column
(
90:10 n-hex: IPA, flow rate 0.5 ml/min, 215 nm); major enantio-
1
= 51.62 min; 80% ee; 1
H
2
mer t
NMR (CDCl
1
= 23.9 min, minor enantiomer t
2
= 27.9 min; 86% ee;
H
mer t
NMR (CDCl
d, J = 6.9 Hz), 7.26–7.54 (3H, m), 7.84–7.88 (4H, m); C NMR
(CDCl , d ppm): 71.2, 81.2, 123.2, 125.3, 126.7, 126.7, 127.8,
28.1, 129.0, 133.2, 133.4 and 135.4.
1
= 36.13 min, minor enantiomer t
3
, d ppm): 2.38 (3H, s), 2.81 (1H, s), 4.50–4.65 (2H, m),
3
, d ppm): 3.04 (1H, br s), 4.54–4.82 (2H, m), 5.61 (1H,
13
13
5
.37–5.45 (1H, m), 7.23–7.32 (4H, m); C NMR (CDCl
3
, d ppm):
2
1.4, 71.1, 81.8, 123.0, 126.6, 128.9, 129.7, 138.0 and 138.9.
3
1
4
.2.9. (R)-1-(2-Methylphenyl)-2-nitroethanol (R)-3i
This compound was prepared according to the Section 4.2 and
4.2.15. (R)-1-(2-Fural)-2-nitroethanol (R)-3o
purified by column chromatography (Hexane–EtOAc 5:1) to give
a colorless oil (70% yield); HPLC analysis: Chiralcel OD-H column
This compound was prepared according to the Section 4.2 and
purified by column chromatography (Hexane–EtOAc 5:1) to give
a yellow oil (80% yield); HPLC analysis: Chiralcel OJ-H column
(90:10 n-hex: IPA, flow rate 1.0 ml/min, 215 nm); major enantio-
(
90:10 n-hex: IPA, flow rate 0.5 ml/min, 215 nm); major enantio-
1
mer t
NMR (CDCl
.60 (2H, m), 5.67–5.72 (1H, m), 7.25–7.31 (3H, m), 7.51–7.56
1
2
= 23.29 min, minor enantiomer t = 36.60 min; 87% ee; H
, d ppm): 2.40 (3H, s), 2.72 (1H, d, J = 3.6 Hz), 4.42–
mer t
NMR (CDCl
5.50 (1H, m), 6.38–6.40 (2H, m), 7.40–7.42 (1H, m); C NMR
(CDCl , d ppm): 64.9, 78.4, 108.2, 100.7, 143.2 and 150.7.
1
= 23.08 min, minor enantiomer t
= 28.49 min; 85% ee; 1
H
2
3
4
3
, d ppm): 2.90 (1H, br s), 4.63–4.84 (2H, m), 5.40–
1
3
13
(
1H, m); C NMR (CDCl
3
, d ppm): 18.9, 68.0, 80.2, 125.6, 126.8,
1
28.8, 130.9, 134.4 and 136.2.
3
4
.2.10. (R)-1-(4-Phenylphenyl)-2-nitroethanol (R)-3j
4.2.16. (R)-1-Nitrohexan-2-ol (R)-3p
This compound was prepared according to the Section 4.2 and
This compound was prepared according to the Section 4.2 and
purified by column chromatography (Hexane–EtOAc 5:1) to give
a yellow oil (76% yield); HPLC analysis: Chiralcel AD-H column
(98:2 n-hex: IPA, flow 0.8 ml/min, 215 nm); major enantiomer
purified by column chromatography (Hexane–EtOAc 5:1) to give
a pale yellow crystalline solid (80% yield); HPLC analysis: Chiralcel
OD-H column (85:15 n-hex: IPA, flow rate 0.8 ml/min, 215 nm);
major enantiomer t
min; 82% ee; H NMR (CDCl , d ppm): 2.88 (1H, d, J = 3.3 Hz),
.36–4.69 (2H, m), 5.52 (1H, d, J = 9.3 Hz), 7.34–7.64 (9H, m);
1
= 19.54 min, minor enantiomer t
2
= 23.80
t
1
= 37.80 min, minor enantiomer t
= 50.51 min; 88% ee; 1H NMR
2
1
3
(CDCl , d ppm): 0.94 (3H, t, J = 6.9 Hz), 1.34–1.61 (6H, m), 2.54
3
1
3
13
4
C
(1H, br s), 4.31–4.49 (3H, m); C NMR (CDCl
3
, d ppm): 13.9,
3
NMR (CDCl , d ppm): 70.8, 81.2, 126.4, 127.1, 127.7, 127.8, 128.9,
22.4, 27.3, 33.4, 68.7 and 80.6.
1
37.0, 140.3 and 142.0.
4
.2.17. (R)-1-Nitropentan-2-ol (R)-3q
This compound was prepared according to the Section 4.2 and
4
.2.11. (R)-1-(4-Methoxyphenyl)-2-nitroethanol (R)-3k
This compound was prepared according to the Section 4.2 and
purified by column chromatography (Hexane–EtOAc 5:1) to give
a yellow oil (60% yield); HPLC analysis: Chiralcel OD-H column
purified by column chromatography (Hexane–EtOAc 5:1) to give
a yellow oil (73% yield); HPLC analysis: Chiralcel AD-H column
(98:2 n-hex: IPA, flow 1.0 ml/min, 215 nm); major enantiomer
(
85:15 n-hex: IPA, flow rate 0.8 ml/min, 215 nm); major enantio-
t
1
= 33.70 min, minor enantiomer t
= 57.18 min; 90% ee; 1H NMR
2
1
mer t
NMR (CDCl
m), 5.62–5.68 (1H, m), 6.93 (2H, d, J = 8.7 Hz), 7.26–7.34 (2H, m);
1
= 17.01 min, minor enantiomer t
2
= 21.78 min; 89% ee;
H
(CDCl , d ppm): 0.98 (3H, t, J = 6.9 Hz), 1.50–1.59 (4H, m), 2.53
3
1
3
3
, d ppm): 2.73 (1H, br s), 3.81 (3H, s), 4.45–4.66 (2H,
(1H, br s), 4.35–4.46 (3H, m); C NMR (CDCl
3
, d ppm): 13.7,
18.4, 35.8, 68.4 and 80.7.
1
3
3
C NMR (CDCl , d ppm): 55.4, 70.7, 81.3, 114.4, 127.3, 130.2 and
1
60.1.
4.2.18. (R)-1-Nitrodecan-2-ol (R)-3r
This compound was prepared according to the Section 4.2 and
purified by column chromatography (Hexane–EtOAc 5:1) to give
a yellow oil (72% yield); HPLC analysis: Chiralcel AD-H column
(98:2 n-hex: IPA, flow rate 1.0 ml/min, 215 nm); major enantiomer
4
.2.12. (R)-1-(3-Methoxyphenyl)-2-nitroethanol (R)-3l
This compound was prepared according to the Section 4.2 and
purified by column chromatography (Hexane–EtOAc 4:1) to give
a yellow oil (75% yield); HPLC analysis: Chiralcel OD-H column
t
1
= 23.09 min, minor enantiomer t
(CDCl , d ppm): 0.88 (3H, t, J = 6.3), 1.47–1.50 (14H, m), 2.49 (1H,
d, J = 4.5 Hz), 4.34–4.47 (3H, m); C NMR (CDCl
22.6, 25.2, 29.2, 29.3, 29.4, 31.8, 33.7, 68.7 and 80.6.
= 36.73 min; 91% ee; 1H NMR
2
(
90:10 n-hex: IPA, flow rate 0.5 ml/min, 215 nm); major enantio-
3
1
13
mer t
NMR (CDCl
1
= 48.22 min, minor enantiomer t
2
= 63.57 min; 90% ee;
H
3
, d ppm): 14.1,
3
, d ppm): 2.97 (1H, br s), 3.19 (3H, s), 4.72–4.84 (2H,